Edition:
United Kingdom

Avinger Inc (AVGR.OQ)

AVGR.OQ on NASDAQ Stock Exchange Capital Market

1.33USD
16 Feb 2018
Change (% chg)

$-0.17 (-11.33%)
Prev Close
$1.50
Open
$1.55
Day's High
$1.55
Day's Low
$1.27
Volume
101,327
Avg. Vol
17,149
52-wk High
$116.00
52-wk Low
$1.27

Chart for

About

Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascul... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $7.83
Shares Outstanding(Mil.): 23.91
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 148.59 16.64
EPS (TTM): -- -- --
ROI: -- 9.38 10.66
ROE: -- 14.72 14.30

BRIEF-Avinger Enteres Into Amendment Of Loan Agreement With CRG Partners

* AVINGER - ON FEB 14, CO ENTERED INTO AMENDMENT NO. 2 TO SEPT. 22, 2015 TERM LOAN AGREEMENT WITH CRG PARTNERS III L.P., CERTAIN AFFILIATED FUNDS

15 Feb 2018

BRIEF-Avinger Says Signed Waiver Agreement With CRG Partners III And Certain Of Its Affiliated Funds, As Lenders​

* AVINGER SAYS‍ ON JAN 24, ENTERED INTO WAIVER AGREEMENT WITH CRG PARTNERS III L.P. & CERTAIN OF ITS AFFILIATED FUNDS, AS LENDERS - SEC FILING​

30 Jan 2018

BRIEF-Avinger Announces Reverse Stock Split

* ‍COMPANY WILL EFFECT A 1-FOR-40 REVERSE STOCK SPLIT OF COMPANY'S COMMON STOCK​

30 Jan 2018

BRIEF-Avinger Inc Files For Common Stock Offering Of Up To $15 Mln

* AVINGER INC FILES FOR COMMON STOCK OFFERING OF UP TO $15.0 MILLION - SEC FILING Source text (http://bit.ly/2r1hfbc) Further company coverage:

12 Jan 2018

BRIEF-Avinger Receives CE Marking Approval For Next Generation Pantheris Image-Guided Atherectomy Device

* AVINGER RECEIVES CE MARKING APPROVAL FOR NEXT GENERATION PANTHERIS IMAGE-GUIDED ATHERECTOMY DEVICE Source text for Eikon: Further company coverage:

20 Dec 2017

BRIEF-Avinger Secures Waiver And Consent To CRG Loan Agreement

* AVINGER SECURES WAIVER AND CONSENT TO CRG LOAN AGREEMENT Source text for Eikon: Further company coverage:

14 Dec 2017

BRIEF-Avinger Says Executive Chairman John Simpson Will Be Leaving Company

* AVINGER INC - JOHN B. SIMPSON, FOUNDER AND EXECUTIVE CHAIRMAN OF AVINGER, WILL BE LEAVING COMPANY

11 Dec 2017

BRIEF-Avinger Q3 loss per share $0.43

* Avinger Inc - ‍cash and cash equivalents totaled $10.2 million as of Sept 30, 2017, compared to $14.0 million as of June 30, 2017​ Source text for Eikon: Further company coverage:

09 Nov 2017

BRIEF-Avinger enters common stock purchase agreement for up to $15.0 mln with Lincoln Park Capital

* Avinger enters into common stock purchase agreement for up to $15.0 million with Lincoln Park Capital Source text for Eikon: Further company coverage:

06 Nov 2017

BRIEF-Avinger receives CE marking approval for in-stent restenosis treatment

* Avinger receives CE marking approval for in-stent restenosis treatment indication with pantheris image-guided atherectomy

26 Sep 2017

Earnings vs. Estimates